- Home
- IMAB vs USEG Comparison
IMAB vs USEG Comparison
Compare IMAB & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- USEG
- Stock Information
- Founded
- IMAB 2014
- USEG 1966
- Country
- IMAB United States
- USEG United States
- Employees
- IMAB N/A
- USEG N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- USEG Oil & Gas Production
- Sector
- IMAB Health Care
- USEG Energy
- Exchange
- IMAB Nasdaq
- USEG Nasdaq
- Market Cap
- IMAB 200.9M
- USEG 42.2M
- IPO Year
- IMAB 2020
- USEG N/A
- Fundamental
- Price
- IMAB $2.13
- USEG $1.32
- Analyst Decision
- IMAB Strong Buy
- USEG Strong Buy
- Analyst Count
- IMAB 3
- USEG 1
- Target Price
- IMAB $6.33
- USEG $3.50
- AVG Volume (30 Days)
- IMAB 589.5K
- USEG 4.1M
- Earning Date
- IMAB 05-15-2025
- USEG 08-06-2025
- Dividend Yield
- IMAB N/A
- USEG N/A
- EPS Growth
- IMAB N/A
- USEG N/A
- EPS
- IMAB N/A
- USEG N/A
- Revenue
- IMAB N/A
- USEG $16,340,000.00
- Revenue This Year
- IMAB N/A
- USEG $23.82
- Revenue Next Year
- IMAB N/A
- USEG N/A
- P/E Ratio
- IMAB N/A
- USEG N/A
- Revenue Growth
- IMAB N/A
- USEG N/A
- 52 Week Low
- IMAB $0.60
- USEG $0.81
- 52 Week High
- IMAB $3.08
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- IMAB 49.76
- USEG 46.13
- Support Level
- IMAB $2.06
- USEG $1.30
- Resistance Level
- IMAB $2.41
- USEG $1.40
- Average True Range (ATR)
- IMAB 0.33
- USEG 0.10
- MACD
- IMAB -0.07
- USEG -0.03
- Stochastic Oscillator
- IMAB 12.63
- USEG 12.95
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.